# COLUMBIA UNIVERSITY HEALTH SCIENCES: Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | COLUMBIA UNIVERSITY HEALTH SCIENCES |
| Location | NEW YORK, NY |
| Project | Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial) |
| Project number | 5R01FD007829-04 |
| Mechanism | R01 |
| Institute | Food and Drug Administration |
| Award | $647,471 |
| Awarded | 2026-09-25 |
| Project period | 2025-09-03 to 2028-05-31 |
| UEI | QHF5ZZ114M72 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11112440). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.